Cellectar Biosciences
CLRB
CLRB
38 hedge funds and large institutions have $6.77M invested in Cellectar Biosciences in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
54% less capital invested
Capital invested by funds: $14.9M → $6.77M (-$8.1M)
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$415K | |
| 2 | +$334K | |
| 3 | +$132K | |
| 4 |
Bank of New York Mellon
New York
|
+$86.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$82.7K |
Top Sellers
| 1 | -$4.66M | |
| 2 | -$523K | |
| 3 | -$508K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$354K |
| 5 |
Two Sigma Advisers
New York
|
-$268K |